Arcus Biosciences Inc — Cash Flow (NYSE:RCUS) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 111.17 M256.17 M438 M306 M170 M482 M 482 M Cash from investing activities 434.37 M3.87 M413 M194 M84 M66 M 66 M Cash from financing activities 438.68 M237.34 M33 M33 M277 M488 M 488 M Free cash flow 108.11 M230.09 M432 M282 M164 M480 M 480 M

新闻

Arcus Biosciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:RCUS) 2026-02-27

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline

Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change

Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues

Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript

Arcus 2025年投资者报告:casdatifan数据增强,免疫学管线浮现

Arcus 2025 presentation: casdatifan data strengthens, I&I pipeline emerges

Arcus Biosciences earnings beat by $0.21, revenue fell short of estimates

Arcus Biosciences成焦点:肾癌药物试验结果成关键

Arcus Biosciences in spotlight: Kidney drug trial results at stake